Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcal Infections | 10 | 2020 | 249 | 3.600 |
Why?
|
| Prenatal Care | 12 | 2025 | 346 | 3.560 |
Why?
|
| Streptococcus agalactiae | 9 | 2020 | 102 | 2.840 |
Why?
|
| Pregnancy Complications, Infectious | 12 | 2023 | 500 | 2.770 |
Why?
|
| Antibiotic Prophylaxis | 6 | 2020 | 121 | 2.240 |
Why?
|
| Pregnancy | 53 | 2026 | 7603 | 1.950 |
Why?
|
| Gynecology | 3 | 2019 | 129 | 1.570 |
Why?
|
| Obstetrics | 4 | 2020 | 246 | 1.550 |
Why?
|
| Chorioamnionitis | 2 | 2021 | 44 | 1.400 |
Why?
|
| Version, Fetal | 2 | 2020 | 5 | 1.330 |
Why?
|
| Infectious Disease Transmission, Vertical | 4 | 2020 | 259 | 1.170 |
Why?
|
| Social Media | 2 | 2022 | 119 | 1.140 |
Why?
|
| Postpartum Period | 4 | 2026 | 239 | 1.110 |
Why?
|
| Diabetes, Gestational | 2 | 2026 | 113 | 1.040 |
Why?
|
| Postpartum Hemorrhage | 2 | 2025 | 111 | 1.010 |
Why?
|
| Sepsis | 3 | 2014 | 496 | 0.900 |
Why?
|
| Cesarean Section | 7 | 2023 | 437 | 0.880 |
Why?
|
| Periodicals as Topic | 2 | 2019 | 181 | 0.870 |
Why?
|
| Anti-Bacterial Agents | 5 | 2020 | 2567 | 0.860 |
Why?
|
| Female | 60 | 2026 | 71430 | 0.850 |
Why?
|
| Pregnancy Trimester, Third | 4 | 2020 | 126 | 0.820 |
Why?
|
| Labor Stage, Second | 1 | 2023 | 14 | 0.790 |
Why?
|
| Delphi Technique | 2 | 2024 | 267 | 0.790 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2020 | 22 | 0.760 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2022 | 31 | 0.730 |
Why?
|
| Surgical Mesh | 1 | 2022 | 65 | 0.730 |
Why?
|
| Endometritis | 1 | 2021 | 9 | 0.720 |
Why?
|
| Neonatal Sepsis | 1 | 2022 | 40 | 0.720 |
Why?
|
| Humans | 71 | 2026 | 132158 | 0.710 |
Why?
|
| Breech Presentation | 2 | 2020 | 18 | 0.710 |
Why?
|
| Penicillins | 2 | 2020 | 154 | 0.700 |
Why?
|
| Delivery, Obstetric | 4 | 2024 | 260 | 0.700 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2023 | 683 | 0.620 |
Why?
|
| Vulvar Lichen Sclerosus | 1 | 2019 | 9 | 0.610 |
Why?
|
| Sexism | 1 | 2019 | 41 | 0.610 |
Why?
|
| Prenatal Diagnosis | 2 | 2018 | 653 | 0.600 |
Why?
|
| Telemedicine | 4 | 2025 | 518 | 0.590 |
Why?
|
| Platelet Count | 1 | 2019 | 140 | 0.580 |
Why?
|
| Genitalia, Female | 1 | 2019 | 49 | 0.580 |
Why?
|
| Cervix Uteri | 2 | 2017 | 59 | 0.580 |
Why?
|
| Lacerations | 1 | 2019 | 32 | 0.570 |
Why?
|
| Drug Hypersensitivity | 1 | 2020 | 97 | 0.570 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2019 | 84 | 0.570 |
Why?
|
| Liability, Legal | 1 | 2018 | 49 | 0.560 |
Why?
|
| Carrier State | 2 | 2015 | 80 | 0.560 |
Why?
|
| Fetal Death | 1 | 2018 | 120 | 0.560 |
Why?
|
| Stillbirth | 1 | 2018 | 103 | 0.540 |
Why?
|
| Patient Preference | 1 | 2019 | 147 | 0.540 |
Why?
|
| Obstetric Labor Complications | 4 | 2024 | 96 | 0.530 |
Why?
|
| Infant, Newborn | 13 | 2023 | 8613 | 0.530 |
Why?
|
| Pandemics | 3 | 2022 | 1168 | 0.510 |
Why?
|
| Betacoronavirus | 1 | 2020 | 287 | 0.510 |
Why?
|
| Parturition | 1 | 2017 | 67 | 0.500 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2026 | 1420 | 0.490 |
Why?
|
| Bias | 1 | 2017 | 145 | 0.490 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 230 | 0.470 |
Why?
|
| Adult | 26 | 2026 | 31755 | 0.450 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 367 | 0.450 |
Why?
|
| Pregnancy Complications | 5 | 2022 | 547 | 0.450 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 378 | 0.450 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 1252 | 0.430 |
Why?
|
| Pregnancy Outcome | 7 | 2024 | 630 | 0.430 |
Why?
|
| Retrospective Studies | 16 | 2026 | 17763 | 0.400 |
Why?
|
| Physicians | 1 | 2019 | 637 | 0.380 |
Why?
|
| United States | 9 | 2024 | 11867 | 0.380 |
Why?
|
| Internship and Residency | 1 | 2022 | 1220 | 0.350 |
Why?
|
| Anticoagulants | 2 | 2026 | 602 | 0.340 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 3096 | 0.330 |
Why?
|
| Biomedical Research | 1 | 2017 | 561 | 0.330 |
Why?
|
| Cerclage, Cervical | 2 | 2007 | 11 | 0.320 |
Why?
|
| Erythromycin | 2 | 2021 | 19 | 0.300 |
Why?
|
| Glucose Tolerance Test | 2 | 2026 | 203 | 0.280 |
Why?
|
| Genetic Testing | 1 | 2014 | 1107 | 0.270 |
Why?
|
| Hospitals, Community | 2 | 2007 | 52 | 0.270 |
Why?
|
| Uterus | 2 | 2007 | 557 | 0.260 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 545 | 0.260 |
Why?
|
| Constriction, Pathologic | 2 | 2007 | 228 | 0.260 |
Why?
|
| Gestational Age | 3 | 2023 | 1237 | 0.260 |
Why?
|
| Hospitals, University | 1 | 2007 | 103 | 0.250 |
Why?
|
| Case-Control Studies | 3 | 2025 | 3458 | 0.250 |
Why?
|
| Parity | 2 | 2024 | 84 | 0.250 |
Why?
|
| Thrombosis | 2 | 2026 | 497 | 0.250 |
Why?
|
| Candidiasis, Vulvovaginal | 1 | 2006 | 3 | 0.240 |
Why?
|
| Prothrombin Time | 1 | 2006 | 36 | 0.240 |
Why?
|
| Societies, Medical | 2 | 2021 | 798 | 0.240 |
Why?
|
| Fluconazole | 1 | 2006 | 48 | 0.240 |
Why?
|
| Dilatation and Curettage | 1 | 2025 | 8 | 0.240 |
Why?
|
| Cerebral Palsy | 1 | 2007 | 86 | 0.230 |
Why?
|
| Hemostasis | 1 | 2026 | 76 | 0.230 |
Why?
|
| Glucose Intolerance | 1 | 2026 | 80 | 0.230 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 1997 | 110 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 3 | 2025 | 1307 | 0.230 |
Why?
|
| Postoperative Hemorrhage | 1 | 2026 | 82 | 0.230 |
Why?
|
| Stakeholder Participation | 1 | 2025 | 35 | 0.230 |
Why?
|
| Blood Coagulation | 1 | 2026 | 133 | 0.220 |
Why?
|
| Warfarin | 1 | 2006 | 123 | 0.220 |
Why?
|
| Blood Loss, Surgical | 1 | 2026 | 170 | 0.220 |
Why?
|
| Pelvic Floor | 1 | 2024 | 37 | 0.210 |
Why?
|
| Time Factors | 4 | 2026 | 6288 | 0.210 |
Why?
|
| Consensus | 2 | 2024 | 530 | 0.210 |
Why?
|
| Delivery of Health Care | 4 | 2023 | 680 | 0.210 |
Why?
|
| Appointments and Schedules | 1 | 2024 | 49 | 0.210 |
Why?
|
| Hemorrhage | 2 | 2026 | 506 | 0.200 |
Why?
|
| Vagina | 3 | 2021 | 215 | 0.200 |
Why?
|
| Fetal Viability | 1 | 2023 | 29 | 0.200 |
Why?
|
| Perioperative Care | 1 | 2026 | 217 | 0.200 |
Why?
|
| Antifungal Agents | 1 | 2006 | 297 | 0.200 |
Why?
|
| Decision Making | 2 | 2020 | 692 | 0.200 |
Why?
|
| Labor Stage, First | 1 | 2023 | 8 | 0.200 |
Why?
|
| China | 1 | 2023 | 288 | 0.190 |
Why?
|
| Maternal Health Services | 1 | 2022 | 47 | 0.180 |
Why?
|
| Surgical Instruments | 1 | 2021 | 56 | 0.180 |
Why?
|
| Azithromycin | 1 | 2021 | 46 | 0.170 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 916 | 0.170 |
Why?
|
| Perinatology | 1 | 2021 | 36 | 0.170 |
Why?
|
| Urinary Retention | 1 | 2021 | 18 | 0.170 |
Why?
|
| Overweight | 2 | 2021 | 379 | 0.170 |
Why?
|
| Morbidity | 1 | 2021 | 262 | 0.170 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2021 | 38 | 0.170 |
Why?
|
| Respiratory Insufficiency | 1 | 2023 | 242 | 0.160 |
Why?
|
| Desogestrel | 1 | 2020 | 7 | 0.160 |
Why?
|
| Hysterectomy | 1 | 2022 | 205 | 0.160 |
Why?
|
| Critical Care | 1 | 2026 | 682 | 0.160 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2021 | 68 | 0.160 |
Why?
|
| Point-of-Care Systems | 1 | 2023 | 206 | 0.160 |
Why?
|
| Contraceptive Agents, Female | 1 | 2020 | 32 | 0.160 |
Why?
|
| Simulation Training | 1 | 2022 | 168 | 0.160 |
Why?
|
| Contraception | 1 | 2020 | 63 | 0.150 |
Why?
|
| Uterine Contraction | 2 | 1997 | 29 | 0.150 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2019 | 33 | 0.150 |
Why?
|
| Attitude of Health Personnel | 1 | 2025 | 721 | 0.150 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 221 | 0.150 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 85 | 0.150 |
Why?
|
| Birth Injuries | 1 | 1999 | 22 | 0.150 |
Why?
|
| Treatment Outcome | 4 | 2026 | 13017 | 0.150 |
Why?
|
| Heart Transplantation | 2 | 2018 | 834 | 0.150 |
Why?
|
| Choice Behavior | 1 | 2019 | 132 | 0.140 |
Why?
|
| Heart Rate, Fetal | 1 | 2018 | 64 | 0.140 |
Why?
|
| Maternal Age | 1 | 2018 | 136 | 0.140 |
Why?
|
| Twins | 2 | 2014 | 71 | 0.140 |
Why?
|
| Pregnancy, Multiple | 2 | 2014 | 44 | 0.140 |
Why?
|
| Probability | 1 | 2018 | 310 | 0.140 |
Why?
|
| Dilatation | 3 | 2024 | 70 | 0.140 |
Why?
|
| Endometriosis | 1 | 2021 | 186 | 0.140 |
Why?
|
| Nausea | 1 | 2018 | 83 | 0.140 |
Why?
|
| Prospective Studies | 5 | 2021 | 6544 | 0.140 |
Why?
|
| Reference Values | 1 | 2019 | 693 | 0.130 |
Why?
|
| Anesthesia | 1 | 2020 | 210 | 0.130 |
Why?
|
| Middle Aged | 5 | 2021 | 28939 | 0.130 |
Why?
|
| Rectus Abdominis | 1 | 1997 | 11 | 0.130 |
Why?
|
| Vomiting | 1 | 2018 | 105 | 0.130 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 187 | 0.130 |
Why?
|
| Abruptio Placentae | 1 | 1997 | 14 | 0.130 |
Why?
|
| Heart Diseases | 2 | 2019 | 505 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2022 | 3134 | 0.130 |
Why?
|
| Heart-Assist Devices | 2 | 2018 | 999 | 0.130 |
Why?
|
| Dystocia | 1 | 1997 | 25 | 0.130 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 236 | 0.120 |
Why?
|
| Hematoma | 1 | 1997 | 90 | 0.120 |
Why?
|
| Terbutaline | 1 | 1996 | 7 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2020 | 424 | 0.120 |
Why?
|
| Tocolytic Agents | 1 | 1996 | 11 | 0.120 |
Why?
|
| Muscular Diseases | 1 | 1997 | 124 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 645 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 459 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2015 | 1235 | 0.120 |
Why?
|
| Chlamydia trachomatis | 1 | 1995 | 30 | 0.120 |
Why?
|
| Gastroplasty | 1 | 1995 | 18 | 0.120 |
Why?
|
| Obstetric Labor, Premature | 1 | 1996 | 77 | 0.120 |
Why?
|
| Coronary Aneurysm | 1 | 1996 | 35 | 0.120 |
Why?
|
| Chlamydia Infections | 1 | 1995 | 54 | 0.120 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 1996 | 51 | 0.120 |
Why?
|
| Risk Factors | 4 | 2026 | 11034 | 0.110 |
Why?
|
| Elective Surgical Procedures | 2 | 2026 | 158 | 0.110 |
Why?
|
| Amoxicillin | 1 | 1995 | 118 | 0.110 |
Why?
|
| Term Birth | 1 | 2014 | 35 | 0.110 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1994 | 30 | 0.110 |
Why?
|
| Recurrence | 2 | 2015 | 1484 | 0.110 |
Why?
|
| Thromboembolism | 1 | 1995 | 92 | 0.110 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1994 | 114 | 0.110 |
Why?
|
| Texas | 3 | 2013 | 3657 | 0.100 |
Why?
|
| Aneuploidy | 1 | 2014 | 141 | 0.100 |
Why?
|
| Quality of Life | 1 | 2024 | 2117 | 0.100 |
Why?
|
| Young Adult | 4 | 2024 | 10126 | 0.100 |
Why?
|
| Fibrinolytic Agents | 1 | 1995 | 200 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1995 | 231 | 0.100 |
Why?
|
| Labor, Obstetric | 1 | 2013 | 99 | 0.100 |
Why?
|
| Catheterization, Central Venous | 1 | 1994 | 142 | 0.100 |
Why?
|
| Forecasting | 1 | 2014 | 360 | 0.100 |
Why?
|
| Bacteriological Techniques | 1 | 2013 | 86 | 0.090 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 4078 | 0.090 |
Why?
|
| Age Factors | 1 | 2019 | 2868 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 739 | 0.090 |
Why?
|
| Michigan | 2 | 2022 | 47 | 0.090 |
Why?
|
| Heart Failure, Systolic | 1 | 2012 | 34 | 0.090 |
Why?
|
| Heart Atria | 1 | 1994 | 338 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2016 | 499 | 0.090 |
Why?
|
| Vaccination | 1 | 2016 | 1040 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2016 | 703 | 0.080 |
Why?
|
| Mass Screening | 1 | 2015 | 821 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1406 | 0.080 |
Why?
|
| Incidence | 2 | 2013 | 3357 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2024 | 979 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 1996 | 1002 | 0.070 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 86 | 0.070 |
Why?
|
| Cervical Length Measurement | 1 | 2007 | 5 | 0.070 |
Why?
|
| Male | 6 | 2019 | 65464 | 0.070 |
Why?
|
| Aged | 3 | 2022 | 21279 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 1916 | 0.060 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2007 | 5 | 0.060 |
Why?
|
| Heart Failure | 1 | 2018 | 2318 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2026 | 3721 | 0.050 |
Why?
|
| Focus Groups | 1 | 2025 | 232 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2021 | 1697 | 0.050 |
Why?
|
| Patient Selection | 1 | 2007 | 727 | 0.050 |
Why?
|
| Adolescent | 2 | 2019 | 21018 | 0.050 |
Why?
|
| Patient Outcome Assessment | 1 | 2023 | 92 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2023 | 5124 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2025 | 711 | 0.040 |
Why?
|
| Prevalence | 1 | 2008 | 2706 | 0.040 |
Why?
|
| Pelvic Pain | 1 | 2021 | 29 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2025 | 1105 | 0.040 |
Why?
|
| Curettage | 1 | 2020 | 6 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2021 | 147 | 0.040 |
Why?
|
| Drug Implants | 1 | 2020 | 43 | 0.040 |
Why?
|
| Puerperal Disorders | 1 | 2020 | 50 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2020 | 52 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 1476 | 0.040 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 162 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2021 | 356 | 0.040 |
Why?
|
| Birth Weight | 1 | 2021 | 347 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 702 | 0.040 |
Why?
|
| Weight Gain | 1 | 2021 | 384 | 0.040 |
Why?
|
| Obesity | 2 | 2021 | 2395 | 0.040 |
Why?
|
| Abdomen, Acute | 1 | 1997 | 13 | 0.030 |
Why?
|
| Counseling | 1 | 2019 | 238 | 0.030 |
Why?
|
| Trial of Labor | 1 | 1997 | 22 | 0.030 |
Why?
|
| Device Removal | 1 | 2018 | 224 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1997 | 272 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 471 | 0.030 |
Why?
|
| Contraindications | 1 | 1996 | 77 | 0.030 |
Why?
|
| Self Report | 1 | 2019 | 564 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2021 | 1004 | 0.030 |
Why?
|
| Arginine | 1 | 2018 | 336 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1838 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1230 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1995 | 82 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 1995 | 133 | 0.030 |
Why?
|
| Cesarean Section, Repeat | 1 | 1994 | 12 | 0.030 |
Why?
|
| History, 20th Century | 1 | 1995 | 365 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 1995 | 233 | 0.020 |
Why?
|
| Rectum | 1 | 2013 | 104 | 0.020 |
Why?
|
| Reoperation | 1 | 1995 | 846 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1995 | 1140 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 414 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2012 | 243 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3858 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2012 | 614 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2018 | 15103 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1081 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2144 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 2154 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2994 | 0.010 |
Why?
|
| Child | 2 | 2018 | 26383 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13355 | 0.010 |
Why?
|
| Premature Birth | 1 | 2007 | 426 | 0.010 |
Why?
|